After regulatory hold-ups in the US and Europe, Ipsen has claimed a confidence-boosting approval in Canada for palovarotene, a rare disease therapy acquired via its $1.3 billion takeover of Clementia ...
Holcim AG, a Swiss construction materials company, has entered into an agreement to sell 83.8% of the shares of Nigerian Lafarge Africa PLC to Chinese company Huaxin Cement Co. This is reported in the ...
The Japanese pharmaceutical company Kyowa Kirin Co. plans to sell shares in the Chinese division of the Hong Kong company WinHealth Pharma Group Co. for 15 billion yen ($100 million) as part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback